Amgen (AMGN) Tops Q3 EPS by 25c, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GMAB
8. USO
9. GOOGL
10. AMD

Go back to Amgen (AMGN) Tops Q3 EPS by 25c, Offers Guidance

AMGEN REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS

November 3, 2022 4:01 PM EDT

THOUSAND OAKS, Calif., Nov. 3, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced financial results for the third quarter of 2022. Key results include:

Total revenues decreased 1% to $6.7 billion in comparison to the third quarter of 2021, resulting from a 1% decline in global product sales, which reflected 8% volume growth offset primarily by 5% lower net selling price and 2% negative impact from foreign exchange. Excluding the 2% negative impact of foreign exchange on product sales, total revenues increased 2%.Volumes grew double-digits for a number of products including LUMAKRAS®/LUMYKRAS... More